Biotech News

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics (DGX)Quest DiagnosticsCompany update

Quest Diagnostics Declares Quarterly Cash Dividend

, / PRNewswire / -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest Diagnostics common stock on October 6, 2026.

About Quest Diagnostics Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com

SOURCE Quest Diagnostics

For further information: For further information: Damini Chokshi (Investors): 201-279-5857 or Wendy Bost (Media): 973-520-2800

Related news

Quest Diagnostics

Diagnostic Information Services Leader Quest Diagnostics provides laboratory testing and diagnostic insights to physicians, hospitals, consumers, and population-health partners. Its core value lies in converting testing data into information that supports disease detection, treatment decisions, and health management. Consumer Access...

Recent company news

Stock data

Close
235.52 USD
Market cap
21.38B USD
Exchange
NYSE
Sector
MedTech
Location
Secaucus, New Jersey